1st Quarter - Report

THE KPM GROUP DC LLC for RARE DISEASE COMPANY COALITION

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.8641 - Orphan Drug COVID-19 Mitigation Act of 2022 (117th) S.46 - American Innovation and Manufacturing Act

LobbyistCovered position, as disclosed
KATHERINE LANDES —
PATROSKI LAWSON —
AMANDA MALAKOFF —
YOKO ROSENBAUM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 46 (118th), H.R. 485 (118th), H.R. 8641 (118th), H.R. 2471 (118th), H.R. 5376 (118th), H.R. 1350 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.